Endocrine Abstracts

Acromegaly is a rare disease that leads to considerable morbidity and mortality, both reversible by adequate control of the disease. However, patients that could be adequately controlled confront delays in achieving treatment targets. The aim of the present study was to estimate the time to disease control after diagnosis and the reason leading to control delays. We retrospectively studied 119 acromegalic patients (aged 46.4±12.5; 71 females). Following appropriate treatm...

Introduction: Hematopoietic stem cell transplantation (HSCT) is the standard of care treatment for high-risk hematological malignancies. HSCT recipients are exposed to chemotherapy and/or radiation prior to HSCT, as part of the conditioning, or following HSCT for management of disease relapse. They may receive steroids for chronic graft-versus-host disease (cGvHD) and they are at high risk for endocrine complications. Aim: To evaluate endocrine complicat...